BMT CTN Protocol 0901

A Randomized, Multi-Center, Phase III Study of Allogeneic Stem Cell Transplantation Comparing Regimen Intensity in Patients with Myelodysplastic Syndrome or Acute Myeloid Leukemia

Below are protocol-related documents, which may be periodically updated.

• Protocol Synopsis, version 5.0 dated March 3, 2014
• Protocol, version 5.0 dated March 3, 2014
• Summary of Changes from version 4.0 to 5.0
• Informed consent, version 5.0 dated March 3, 2014
• Participating Centers
• Frequently Asked Questions
• This study is posted on clinicaltrials.gov as NCT01339910
• Key Personnel

            Protocol Co-Chair: Mitchell Horwitz, MD (919-668-1045) mitchell.horwitz@duke.edu

            Protocol Co-Chair: Bart Scott, MD (206-667-1990) bscott@fhcrc.org

            Protocol Officer: Marcello Pasquini, MD (414-805-0700) mpasquin@mcw.edu

            Acting Protocol Coordinator: Brianne Allison (301-251-1161) ballison@emmes.com

            Medical Monitor: Bipin Savani, MD bipin.savani@vanderbilt.edu

        

           

This study was closed to new patient accrual on April 18, 2014.